COVID-19 pill

The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed to at least that many doses, and could increase…

Early viral clearance (negative RT-PCR) and significant clinical improvement were observed within five days of administering the…

The study has been conducted jointly by Fortis C-DOC, G D Hospital and Diabetes Institute, Jawaharlal Nehru Medical College and…

The step has been taken to increase broad access of COVID-19 treatment in 105 Low- and Middle- Income Countries (LMICs)

The company has received DCGI regulatory license for the Indian market, applicable for both API as well as the finished product

Merck is developing Molnupiravir in collaboration with Ridgeback Biotherapeutics and it has been authorised for use in more than…

The decision is part of Pfizer's strategy to boost global production of the pill, Paxlovid, which was found to be nearly 90 per…

Dr Bhargava had last week said that Molnupiravir has major safety concerns. He added that WHO and the UK have not included it for…

Molulow will come as a pack of 4×10 capsule strips with each capsule in 200 mg strength

Clinical data suggests that it is effective on patients with co-morbidities